This report provides preliminary information about 21 cases of liver injury associated with rifampin-pyrazinamide (RIF-PZA) and the revised recommendations on selecting appropriate therapy for patients with latent TB infection and monitoring the use of RIF-PZA to treat infection.
This manual presents a role-play-based curriculum on how to conduct a contact investigation for persons with TB. It provides scripts and evaluation forms for each role-play session.
This report outlines a strategy for management of human resources for TB control.
In response to the urgent need to control the spread of TB, the U.S. Congress passed the Reauthorization Act supporting a substantial increase in USG funding for TB treatment and control over a five-year period. The Reauthorization Act requests the development of a USG Global Tuberculosis Strategy.
This handbook summarizes the issues, recommended strategies and practical measures involved in addressing the components of the Stop TB Strategy. It provides recommended approaches to implementing the Stop TB Strategy as well as activities that should be addressed by National TB Programs.
This Guide describes how to make TB services 100% tobacco-free, then presents ‘ABC for TB’, an intervention for TB programmes to help patients quit smoking and to promote smokefree homes for patients and families. It advocates keeping cessation simple, expanding it widely through the health services and reaching communities. ‘ABC for TB’ does not require specialised staff, clinics or medicines. It is delivered systematically within routine programme activities and can be done within as little as 2-5 minutes. It includes recording and monitoring processes and outcomes.
This handbook is a reference tool for use by national tuberculosis (TB) program managers, clinicians and nurses, public health decision-makers and technical and implementing partners committed to the prevention, care, diagnosis and treatment of drug-resistant TB.
This monograph provides information for use by tribal, state, and local public health practitioners and their legal counsel to help improve their understanding and use of relevant laws to respond to challenges concerning TB control. Part I of the monograph contains an introduction and table listing resources on communicable disease and TB control methods in selected US jurisdictions. Part II presents a brief overview of some of the essential components of TB control, including a discussion of the international and national threats of the disease and modern public health interventions.
This report presents the Centers for Disease Control and Prevention's (CDC) updated recommendations on the use of nucleic acid amplification tests (NAA) for TB diagnosis. These revised guidelines were developed on the basis of a report by a panel of clinicians, laboratorians, and TB control officials. The panel was convened by CDC and the Association of Public Health Laboratories (APHL) and in consultation with the Advisory Council for the Elimination of TB (ACET).
These new guidelines supersede previous WHO policy documents on the management of LTBI in people living with HIV, household contacts of people with active TB, other groups at risk of developing TB, and for LTBI testing. The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants.
